OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nationwide increases in anti-SARS-CoV-2 IgG antibodies between October 2020 and March 2021 in the unvaccinated Czech population
Pavel Piler, Vojtěch Thon, Lenka Andrýsková, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 11
Pavel Piler, Vojtěch Thon, Lenka Andrýsková, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Age-stratified infection fatality rate of COVID-19 in the non-elderly population
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
Environmental Research (2022) Vol. 216, pp. 114655-114655
Open Access | Times Cited: 95
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
Environmental Research (2022) Vol. 216, pp. 114655-114655
Open Access | Times Cited: 95
Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 12
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 12
Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers
Alexandra Lochmanová, Jan Martínek, Hana Tomášková, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 637-637
Open Access | Times Cited: 7
Alexandra Lochmanová, Jan Martínek, Hana Tomášková, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 637-637
Open Access | Times Cited: 7
Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3703-3703
Open Access | Times Cited: 5
Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3703-3703
Open Access | Times Cited: 5
Investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic: a prospective national cohort study
Vojtěch Thon, Pavel Piler, Tomáš Pavlík, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e068258-e068258
Open Access | Times Cited: 3
Vojtěch Thon, Pavel Piler, Tomáš Pavlík, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e068258-e068258
Open Access | Times Cited: 3
Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Seroprevalence of SARS-CoV-2 Antibodies in Denmark: Results of Two Nationwide Population-Based Surveys, February and May 2021
Lene Wulff Krogsgaard, Laura Espenhain, Siri Tribler, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 301-312
Open Access | Times Cited: 2
Lene Wulff Krogsgaard, Laura Espenhain, Siri Tribler, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 301-312
Open Access | Times Cited: 2
Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Long-Term Immunological Alertness and Response to COVID-19 Vaccination—Conditions for Prevention in Early Palliative Oncological Care Patients
Peter Priester, Miroslav Fajfr, Veronika Molnárová, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 299-299
Open Access
Peter Priester, Miroslav Fajfr, Veronika Molnárová, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 299-299
Open Access
A study of anti-SARS-CoV-2 antibody positivity in Duhok City, Iraq
Nawfal R Hussein, Guleer H Shahab, Narin A. Rasheed, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 07, pp. 937-943
Open Access | Times Cited: 1
Nawfal R Hussein, Guleer H Shahab, Narin A. Rasheed, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 07, pp. 937-943
Open Access | Times Cited: 1
Prospective investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic
Vojtěch Thon, Pavel Piler, Tomáš Pavlík, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Vojtěch Thon, Pavel Piler, Tomáš Pavlík, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
